K2 HealthVentures
855 Boylston Street, 10th Floor, Boston, MA, 02116, United States
Overview
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Hopscotch Primary Care | Aug 2026Participated | $53 MSeries D | |
Stealth BioTherapeutics | Jul 2026Participated | $150 MDebt | |
Honest Health | Feb 2026Participated | $140 MOther Equity | |
Zarminali Health | Jan 2026Participated | $110 MSeries A | |
Apella Technology | Jan 2026Participated | $80 MSeries B | |
Phil | Jul 2025Led | $60 MDebt | |
Umoja Biopharma | Jan 2025Participated | $100 MSeries C | |
Evergreen Nephrology | Jan 2025Participated | $130 MOther Equity | |
HarmonyCares | Jul 2024Participated | $200 MOther Equity | |
Hopscotch Primary Care | Jun 2024Participated | $50 MSeries C | |
Vedanta Biosciences | Apr 2023Participated | $107 MOther Equity | |
Alto Neuroscience | Jan 2023Participated | $60 MDebt | |
Hopscotch Primary Care | Aug 2026Participated | $53 MSeries D | |
Stealth BioTherapeutics | Jul 2026Participated | $150 MDebt | |
Honest Health | Feb 2026Participated | $140 MOther Equity | |
Zarminali Health | Jan 2026Participated | $110 MSeries A | |
Apella Technology | Jan 2026Participated | $80 MSeries B | |
Phil | Jul 2025Led | $60 MDebt | |
Umoja Biopharma | Jan 2025Participated | $100 MSeries C | |
Evergreen Nephrology | Jan 2025Participated | $130 MOther Equity | |
HarmonyCares | Jul 2024Participated | $200 MOther Equity | |
Hopscotch Primary Care | Jun 2024Participated | $50 MSeries C | |
Vedanta Biosciences | Apr 2023Participated | $107 MOther Equity | |
Alto Neuroscience | Jan 2023Participated | $60 MDebt |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 0 | 1 |
| Series B | 0 | 3 |
| Series C+ | 0 | 4 |
| Other Equity | 0 | 5 |
| Debt | 10 | 2 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Sep '19 | 1 |
| Oct '19 | 0 |
| Nov '19 | 0 |
| Dec '19 | 0 |
| Jan '20 | 0 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 1 |
| May '20 | 0 |
| Jun '20 | 0 |
| Jul '20 | 0 |
| Aug '20 | 0 |
| Sep '20 | 1 |
| Oct '20 | 1 |
| Nov '20 | 0 |
| Dec '20 | 1 |
| Jan '21 | 0 |
| Feb '21 | 0 |
| Mar '21 | 0 |
| Apr '21 | 1 |
| May '21 | 0 |
| Jun '21 | 0 |
| Jul '21 | 1 |
| Aug '21 | 1 |
| Sep '21 | 0 |
| Oct '21 | 2 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 1 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 1 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 2 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 1 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 1 |
| Jul '24 | 1 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 2 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 1 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 2 |
| Feb '26 | 1 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 1 |
| Aug '26 | 1 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 24 |
| Food & Agriculture | 3 |
| Clean Energy & Sustainability | 3 |
| Professional Services | 3 |
| AI & Machine Learning | 2 |
| Hardware & Robotics | 1 |
| E-Commerce & Retail | 1 |
| Space & Frontier Tech | 1 |
| Developer Tools | 1 |
| Consumer & Lifestyle | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 0 |
| $10M-$25M | 1 |
| $25M-$50M | 4 |
| $50M-$100M | 11 |
| $100M-$250M | 9 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 24 |
| Singapore | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Oak HC/FT | 5 |
| Rubicon Founders | 3 |
| 8VC | 2 |
| Alumni Ventures | 2 |
| aMoon | 2 |
| Citi | 2 |
| General Catalyst | 2 |
| Revelation Partners | 2 |
| Town Hall Ventures | 2 |
| Valtruis | 2 |
| Accelmed | 1 |
| Alexandria Venture Investments | 1 |
| Alpha Wave Ventures | 1 |
| AMR Action Fund | 1 |
| ARK Invest | 1 |
| Atlantic Neptune | 1 |
| Autism Impact Fund | 1 |
| AXA IM Alts | 1 |
| Bill & Melinda Gates Foundation | 1 |
| Blue Shield of California | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 10 | 40% |
| Participating | 15 | 60% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 10 | 100% |
| Co-led | 0 | 0% |
Team
Founder, Managing Director & CIO
Managing Director
Vice President
Vice President of Finance and Operations
Vice President
Vice President
Managing Director
Founder, Managing Director & CEO